Kasabach-merritt phenomenon: a retrospective study of treatment with vincristine

Journal of Pediatric Hematology/oncology
Camille Haisley-RoysterDenise M Adams

Abstract

Kasabach-Merritt phenomenon (KMP) is characterized by profound thrombocytopenia, microangiopathic hemolytic anemia, a consumptive coagulopathy, and an enlarging vascular lesion. The syndrome develops in infancy and is associated with a high morbidity and mortality rate. The purpose of this study was to assess the effectiveness of vincristine in the treatment of KMP. We retrospectively reviewed the clinical and laboratory data of 15 patients with KMP treated with vincristine at 9 institutions across the United States, South America, and Europe. All 15 patients had profound thrombocytopenia and consumption of fibrinogen at presentation. Ten patients had biopsies of their lesions, and results included five (33.3%) kaposiform hemangioendotheliomas, three (20%) tufted angiomas, one lesion (6.7%) with features of both kaposiform hemangioendothelioma and tufted angioma, and one (6.7%) unclassified vascular tumor. All 15 patients had an increase in platelet count of at least 20,000 with an average response time of 4.0 weeks after initiation of vincristine therapy. Thirteen patients had an increase in fibrinogen level of 50 mg/dL with an average response time of 3.4 weeks. In 13 patients there was a significant decrease in the size of t...Continue Reading

References

Mar 1, 1992·American Journal of Hematology·N T O'ConnorL F Hill
Oct 1, 1991·Pediatric Hematology and Oncology·M F DresseG E Rivard
Apr 1, 1983·Journal of the American Academy of Dermatology·N B Esterly
Jul 6, 1995·The New England Journal of Medicine·J Perez PayarolsC Gomez Bellvert
Apr 1, 1997·The Journal of Pediatrics·O EnjolrasJ P Escande
Oct 6, 1997·International Journal of Radiation Oncology, Biology, Physics·N MitsuhashiH Niibe
May 5, 1999·Critical Reviews in Oncology/hematology·C E GiddingS S de Graaf
Jun 4, 1999·Journal of Clinical Apheresis·A S RamananV Chandrasekaran
Jan 22, 2000·Journal of the American Academy of Dermatology·O EnjolrasH P Kozakewich
Jul 25, 2000·The British Journal of Dermatology·T OhtsukaS Yamazaki

❮ Previous
Next ❯

Citations

Mar 17, 2012·Pediatric Cardiology·Andrea BeatonGerard R Martin
Aug 31, 2013·Pediatric Surgery International·Richard G Azizkhan
Dec 17, 2010·International Journal of Hematology·Yuko WatanabeShigeru Tsuchiya
Feb 6, 2004·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·O EnjolrasG Leverger
Mar 31, 2009·European Journal of Internal Medicine·Y FernándezJ S García-Morillo
Dec 31, 2004·Lymphatic Research and Biology·Mary Wu Chang
Nov 19, 2004·Current Opinion in Otolaryngology & Head and Neck Surgery·Lisa M Buckmiller
Jul 14, 2005·Current Opinion in Pediatrics·Francine Blei
Nov 14, 2006·Current Opinion in Otolaryngology & Head and Neck Surgery·Carol J Macarthur
Nov 18, 2008·Journal of Pediatric Hematology/oncology·Mark A WalshKyong-Jin Lee
Aug 19, 2009·Journal of Pediatric Hematology/oncology·Kip R HartmanKevin M Creamer
Apr 14, 2010·Journal of Pediatric Hematology/oncology·Margreet A VeeningGert-Jan L Kaspers
Jun 5, 2010·Journal of Pediatric Hematology/oncology·Farzan FahrtashSusan Arbuckle
Mar 28, 2009·Annals of Plastic Surgery·Julie C KarnesArin K Greene
Jan 15, 2011·The Journal of Craniofacial Surgery·Mark W StalderRichard J Redett
May 27, 2011·Neurologia Medico-chirurgica·Yukiko EnomotoToru Iwama
Mar 13, 2009·Journal of Neurosurgery. Pediatrics·Won-Sang ChoByung-Kyu Cho
Nov 3, 2009·Journal of Neurosurgery. Pediatrics·Stacey Quintero WolfeMohammad Ali Aziz-Sultan
Jul 27, 2010·Indian Journal of Dermatology, Venereology and Leprology·S Ragunatha, Arun C Inamadar
Jan 28, 2014·Journal of Cancer Research and Clinical Oncology·Li KaiXianmin Xiao
Jun 26, 2014·Case Reports in Hematology·Worawut ChoeyprasertPimlak Charoenkwan
Sep 23, 2014·Seminars in Pediatric Surgery·Denise M Adams, Adrienne Hammill
Jun 13, 2014·BMC Pediatrics·Ping WangXiao-Wen Chen
Aug 14, 2012·ISRN Hematology·Mohamed Radhi, Shannon L Carpenter
Mar 16, 2013·Journal of Clinical Pathology·Felipe D'Almeida Costa, Andrew L Folpe
Sep 1, 2008·Seminars in Interventional Radiology·Sandeep VaidyaManrita Sidhu
May 19, 2012·The Surgical Clinics of North America·R Dawn Fevurly, Steven J Fishman
Mar 1, 2012·Journal of Vascular and Interventional Radiology : JVIR·Ricardo Garcia-MonacoGonzalo Mariani
Nov 26, 2010·Clinics in Plastic Surgery·Arin K Greene
Nov 26, 2010·Clinics in Plastic Surgery·Denise M Adams
Oct 5, 2010·Pediatric Clinics of North America·Michael Kelly
Dec 22, 2009·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·R López AlmarazG Ramírez Villar
Apr 29, 2009·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·V Minard-ColinO Oberlin
Mar 29, 2005·Pediatric Annals·Tara Miller, Ilona J Frieden
Jun 21, 2006·Pediatric Annals·Erin MathesIlona Frieden
Jan 1, 2008·Advances in Dermatology·Odile EnjolrasArnaud Picard
Apr 3, 2008·Pediatric Clinics of North America·Denise M Adams, Mary Sue Wentzel
Jan 22, 2008·Journal of Pediatric Surgery·Francisco Luis San MiguelJohn Horton
Apr 18, 2006·Seminars in Pediatric Surgery·Denise M Adams, Anne W Lucky
Apr 4, 2006·The Surgical Clinics of North America·Emily R Christison-Lagay, Steven J Fishman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.